Venipuncture Procedure Market Size, Share, and Industry Analysis, By Technique (Straight Needle Technique, Butterfly Needle Technique, and Vacutainer Method), Site (Basilic Vein, Median Cubital Vein, and Cephalic Vein), By Provider (Hospital-based Laboratories, Standalone Laboratories, Clinic-based Laboratories, and Others), and Regional Forecast, 2025-2032

The global venipuncture procedure market is witnessing significant growth due to the increasing number of laboratory testing across the globe. Venipuncture or phlebotomy is a process of puncturing a superficial vein to draw blood, usually for lab testing and intravenous therapy.

The market growth is further driven by advancements in testing technology and the introduction of new testing method. Further, the rising prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancer requires regular blood testing, which increases the demand for venipuncture procedures.

• According to the American Clinical Laboratory Association, more than 7.0 billion clinical lab tests are performed in the U.S. each year.

Additionally, increasing awareness among people about early diagnosis and health maintenance is set to increase the demand for venipuncture procedures in the near future.

Venipuncture Procedure Market Driver

Rising Prevalence of Chronic Diseases to Boost Market Growth

The increase in the prevalence of chronic disorders such as cancer, diabetes, hypertension, autoimmune diseases, and heart diseases are expected to drive the market during the forecast timeframe. The factors contributing to the rise in the prevalence of such disorders include increasing geriatric population, tobacco consumption and exposure, physical inactivity, and poor lifestyle.

• According to the Centers for Disease Control and Prevention data published in 2021. Every year, about 805,000 people in the U.S. suffered with heart attack and about 1 in 20 adults aged 20 and older have coronary artery disease (CAD). Such higher prevalence increases the demand for blood testing and venipuncture procedure.

Download Free sample to learn more about this report.

Venipuncture Procedure Market Restraint

Lack of Skilled Professionals May Limit the Market Growth

Venipuncture, the process of obtaining intravenous access for intravenous therapy or venous blood sampling, requires specific skills and training. The lack of such skilled professional can potentially limit the market growth, especially in emerging countries.

• For instance, according to an article published by Clinical Lab Products (CLP) in September 2022, there is a shortage of 20,000 to 25,000 laboratory technologists, including phlebologist. Such high shortage of skilled professionals increases the supply-demand imbalance, which can hinder the market growth over the forecast period.

Venipuncture Procedure Market Opportunity

Soaring Diagnostic Testing Demand to Provide Opportunities for Industry Expansion

Rising demand for diagnostic testing due to increasing prevalence of chronic diseases boosts the demand for blood tests, which directly supports the growth of venipuncture procedures. The need for regular monitoring and diagnostics is expected to create a strong opportunity for blood collection services. Additionally, advances in venipuncture technology, such as improved needles, automated blood collection devices, and point-of-care testing (POCT), enhance the efficiency and safety of blood collection. The integration of these technologies can lead to accurate diagnostics, creating the opportunity for venipuncture procedures.

• For instance, in May 2023, Sonic Healthcare USA partnered with Proteomics International to develop and commercialize PromarkerD to the U.S. market. PromarkerD is a newly developed blood test by Proteomics International to predict a decline in kidney function in type 2 diabetes.

The development of such new advanced blood tests is expected create new market opportunities across the globe.

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries, 2023
• Regulatory Overview of Blood Collection, By Key Countries/ Region, 2023
• Technological Advancements in the Blood Sample Collection
• Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• Impact of COVID-19 on the Market

Segmentation

Analysis by Site

Based on site, the market is segmented into basilic vein, median cubital vein, and cephalic vein.  

The median cubital vein segment accounted for a significant revenue in the market. The median cubital vein is the most commonly used site for venipuncture due to its central location in the arm, ease of access, and lower likelihood of complications. This preference drives a significant share of the market. Additionally, the procedures involving the median cubital vein typically have a higher success rate as these are easily visible, which encourages healthcare providers to favor this site for blood collection.

• For instance, a voluntary study published in the Journal of Patient Safety in March 2020 stated that 90.0% to 95.0% of patients has higher visibility for the median cubital vein, increasing patient safety and making it the preferred site for venipuncture procedure.

Analysis by Technique

Based on technique, the market is segmented into straight needle technique, butterfly needle technique, and vacutainer method.

The straight needle technique segment accounted for a significant share in the market. This technique is highly preferred as it allows for swift blood collection, making them suitable for multiple samples in one procedure. Their design facilitates quick access to the vein and efficient blood flow into the collection tube. These factors are enabling the segment to hold significant share in the market.

Analysis by Provider

Based on provider, the market is categorized into hospital-based laboratories, standalone laboratories, clinic-based laboratories, and others.

The hospital-based laboratories segment accounted for a significant share in the market. The segment is expected to grow at a significant CAGR over the forecast period. The growth of the segment attributed to the higher number of sample collection in the facilities. Additionally, the increased demand for blood transfusion diagnostics in hospitals is expected to drive segment growth in the near future. Moreover, the expansion of hospital chains is expected to increase patient visits and consequent sample collection.

• For instance, in November 2023, Rainbow Children's Hospital in India announced the expansion of its hospital chain with four new facilities. This can increase patient visits in these facilities.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the market in 2023. The increasing prevalence of chronic diseases coupled with the growing demand for clinical laboratory tests for regular body check-ups and disease diagnosis is expected to drive the market growth.

• For instance, according to a report published by the Journal of the American Heart Association (JAHA), approximately 55.0% to 98.0% of adults over 60 years have at least 2 chronic diseases, and ischemic heart disease, which increases the demand for regular blood sample collection for lab testing and treatment.

Europe is the second-largest market due to the well-established healthcare systems, stringent regulatory frameworks and increasing geriatric population that requires blood testing for diagnosis and long-term care.

The Asia Pacific market is expected to grow at a higher CAGR during the forecast period. Increasing focus of key players on regional expansion of their clinical laboratories and the introduction of technologically advanced testing are expected to drive the market in the region.

Key Players Covered

The global venipuncture procedure market is fragmented.

The report includes the profiles of the following key players:

• Laboratory Corporation of America Holdings (U.S.)
• Quest Diagnostics (U.S.)
• Eurofins Scientific (Luxembourg)
• BioReference Health, LLC (U.S.)
• UNILABS (Switzerland)
• Mayo Clinic Laboratories (U.S.)
• Charles River Laboratories (U.S.)
• OPKO Health, Inc. (U.S.)

Key Industry Developments

• In April 2023, SRL Diagnostics acquired Lifeline laboratories to expand its presence in the Indian pathology market.
• In March 2023, Laboratory Corporation of America announced the acquisition of Biochem's Clinical Lab Business for USD 146.0 million to provide better testing services in the U.S.
• In January 2022, Eurofins Scientific through its subsidiary empowerDX launched PFAS Exposure service in the U.S. It is the first at-home blood test to detect and measure 40+ PFAS compounds. Such unique services strengthen their service portfolio.